Many IBD 50 Stocks Struggle To Climb After Breakouts

Investor's Business Daily - Investing RSS http://ift.tt/1qCu6pO A number of IBD 50 stocks have cleared buy points recently, but many of them have made little progress. Noneof the stocks is flashing a sell signal, but many of the bases are riskier late-stage patterns. As a result, investors should remain vigilant, especially since these stocks so far aren't providing much of a cushion against a potential sell-off. Facebook (FB) cleared a 66.57 buy point of a cup-with-handle base on Tuesday, but volume was weak